瘤塑性乳房保护手术 (OBCS) 与乳房切除与重建:在服务不足的人群中对结果的比较
Angela Foley1, Adrian Choppa1, Fardeen Bhimani2
1Albert Einstein College of Medicine, Bronx, NY, USA.
Gland surgery
|April 11, 2024
概括
瘤塑性乳房保护手术 (OBCS) 提供了比乳房切除更好的患者满意度和更少的并发症,即使对于较大的瘤. 这种方法对多样化和服务不足的人群特别有益,保持瘤安全.
科学领域:
- 手术瘤学手术瘤学
- 整形外科 整形外科 整形外科
- 医疗保健服务研究 医疗服务研究
背景情况:
- 瘤塑性乳房保护手术 (OBCS) 显示出比传统的乳房保护手术 (BCS) 更好的美容效果.
- 关于影响OBCS健康的社会决定因素与乳腺切除结果的研究有限.
- 目前,OBCS被认为对较大 (>5厘米) 和多焦点瘤是安全的,以前使用乳房切除术治疗.
研究的目的:
- 用患者报告的结果 (PRO) 和瘤测量方法,将瘤塑性乳房保护手术 (OBCS) 与乳房切除术进行比较.
- 通过种族,种族和体重指数 (BMI) 来分层分析结果.
- 评估OBCS在患有大或多焦点乳腺癌的患者的安全性和有效性.
主要方法:
- 对57名OBCS和204名乳腺切除术患者 (2015-2021) 的回顾性审查.
- 收集的数据:年龄,种族,种族,BMI,保险,手术类型,病理,复发,并发症.
- 用BREAST-Q进行手术前和手术后评估的患者报告结果.
主要成果:
- OBCS患者报告说,尽管BMI较高,但对乳房和结果的满意度更高.
- 在西班牙裔或非裔美国患者的OBCS和乳房切除术之间没有发现显著的PRO差异.
- 与乳腺切除术相比,OBCS的感染率较低,额外手术较少,瘤结果类似 (边缘,复发).
结论:
- 在保持瘤安全的同时,OBCS提供了优越的患者报告结果和比乳房切除术更少的并发症.
- 这些发现支持在多样化和服务不足的人群中利用OBCS,包括那些有较大的瘤的人群.
- 需要对更大,更多样化的群体进行进一步的研究来证实这些好处,特别是对于没有保险的群体.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
261
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
6.6K
相关概念视频
01:20Comparing the Survival Analysis of Two or More Groups
179
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
179
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
01:24Kaplan-Meier Approach
135
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
135